Brewer M, Angioli R, Scambia G, Lorusso D, et al. Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study. Gynecol Oncol 2020 Jan 6. pii: S0090-8258(19)31845.
PMID: 31916979